Drug interactions for the following drug(s)
Applies to: doxycycline hyclate 100 MG Oral Tablet <> RETIN-A MICRO 0.04 % Topical Gel
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Tretinoin is combined with Doxycycline.
Applies to: RETIN-A MICRO 0.04 % Topical Gel <> doxycycline hyclate 100 MG Oral Tablet
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Tretinoin is combined with Doxycycline.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: doxycycline hyclate 100 MG Oral Tablet <> RETIN-A MICRO 0.04 % Topical Gel
Drug1 (rxcui = 1650143, name = doxycycline hyclate 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 805370, name = tretinoin 0.0004 MG/MG Topical Gel [Retin-A], tty = SBD). Drug1 is resolved to doxycycline, Drug2 is resolved to tretinoin and interaction asserted in DrugBank between Doxycycline and Tretinoin.
Applies to: RETIN-A MICRO 0.04 % Topical Gel <> doxycycline hyclate 100 MG Oral Tablet
Drug1 (rxcui = 805370, name = tretinoin 0.0004 MG/MG Topical Gel [Retin-A], tty = SBD). Drug2 (rxcui = 1650143, name = doxycycline hyclate 100 MG Oral Tablet, tty = SCD). Drug1 is resolved to tretinoin, Drug2 is resolved to doxycycline anhydrous and interaction asserted in DrugBank between Tretinoin and Doxycycline.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.